Interstitial lung disease related to smoking: Imaging considerations

Current Opinion in Pulmonary Medicine

Volumn 21, Issue 4, 2015, Pages 407-416

  Walsh, Simon L F ^a   Nair, Arjun ^b   Desai, Sujal R ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diffuse Parenchymal Lung Disease; Imaging; Smoking Related Lung Disease; Tomography; X Ray Computed

Indexed keywords

TOBACCO SMOKE;

BRONCHIOLITIS; COMPUTER ASSISTED TOMOGRAPHY; DESQUAMATIVE INTERSTITIAL PNEUMONIA; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LANGERHANS CELL HISTIOCYTOSIS; LUNG FIBROSIS; RESPIRATORY BRONCHIOLITIS; RESPIRATORY BRONCHIOLITIS INTERSTITIAL LUNG DISEASE; REVIEW; SMOKING; THORAX RADIOGRAPHY; LANGERHANS CELL;

BRONCHIOLITIS; HUMANS; LANGERHANS CELLS; LUNG DISEASES, INTERSTITIAL; PULMONARY FIBROSIS; SMOKING;

EID: 84942844111     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000178     Document Type: Review

References (105)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin 2005; 55:74-108.
2. World Health Organization. Chronic obstructive pulmonary disease (COPD)-Fact sheet No 315. WHO 2013. http://www.who.int/media centre/factsheets/fs315/en/.
3. Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983; 14:847-856.
4. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): A clinicopathologic study of 48 cases. Am J Surg Pathol 1993; 17:971-986.
5. Colby TV, Carrington CB. Interstitial lung disease. In: Thurlbeck WM, Churg AM, editors. Pathology of the lung, 2nd ed. New York: Thieme Medical Publishers; 1995. pp. 589-737.
6. Snider GL, Kleinerman J, Thurlbeck WM, Bengali ZH. The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 1985; 132: 182-185.
7. Cardoso WV, Sekhon HS, Hyde DM, Thurlbeck WM. Collagen and elastin in human pulmonary emphysema. Am Rev Respir Dis 1993; 147:975-981.
8. Lang MR, Fiaux GW, Gillooly M, et al. Collagen content of alveolar wall tissue in emphysematous and nonemphysematous lungs. Thorax 1994; 49:319-326.
9. Tonelli M, Stern EJ, Glenny RW. HRCT evident fibrosis in isolated pulmonary emphysema. J Comput Assist Tomogr 1997; 21:322-323.
10. Weiss W. Cigarette smoking and diffuse pulmonary fibrosis. Am Rev Respir Dis 1969; 99:67-72.
11. Niewoehner DE, Hoidal JR. Lung fibrosis and emphysema: divergent responses to a common injury? Science 1982; 217:359-360.
12. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155:242-248.
13. Wright JL, Tazelaar HD, Churg A. Fibrosis with emphysema. Histopathology 2011; 58:517-524.
14. Samara KD, Margaritopoulos G, Wells AU, et al. Smoking and pulmonary fibrosis: novel insights. Pulmonary Med 2011; 2011:. [Epub ahead of print]
15. Katzenstein A-LA. Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases. J Clin Pathol 2013; 66:882-887.
16. Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 2010; 41:316-325.
17. Grubstein A, Bendayan D, Schactman I, et al. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med 2005; 99:948-954.
18. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: A distinct underrecognised entity. Eur Respir J 2005; 26: 586-593.
19. Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35:105-111.
20. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: The value of high resolution computed tomography in assessment. Respir Med 1990; 84:365-369.
21. Grana N. Langerhans cell histiocytosis. Cancer Contr 2014; 21:328-334.
22. Favara BE, Feller AC. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997; 29:157-166.
23. Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001; 25:630-636.
24. Willman CL, Busque L, Griffith BB, et al. Langerhans-cell histiocytosis (histiocytosis X)-A clonal proliferative disease. N Engl J Med 1994; 331:154-160.
25. Burns BF, Colby TV, Dorfman RF. Langerhans cell granulomatosis (histiocytosis X) associated with malignant lymphomas. Am J Surg Pathol 1983; 7:529-533.
26. Neumann MP, Frizzera G. The coexistence of Langerhans cell granulomatosis and malignant lymphoma may take different forms: report of seven cases with a review of the literature. Hum Pathol 1986; 17:1060-1065.
27. Tomashefski JF, Khiyami A, Kleinerman J. Neoplasms associated with pulmonary eosinophilic granuloma. Arch Pathol Lab Med 1991; 115:499-506.
28. Howarth DM, Gilchrist GS, Mullan BP, et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999; 85:2278-2290.
29. Brown NA, Furtado LV, Betz BL, et al. High prevalence of somatic MAP2K1 mutations in BRAF V600E negative Langerhans cell histiocytosis. Blood 2014; 124:1655-1658.
30. Badalian-Very G, Vergilio J-A, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 2010; 116:1919-1923.
31. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949-954.
32. Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans cell histiocytosis. N Engl J Med 2000; 342:1969-1978.
33. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol 2008; 32:615-619.
34. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary pulmonary histiocytosis in the adult. Medicine 1981; 60:385-396.
35. Casolaro MA, Bernaudin J-F, Saltini C, et al. Accumulation of Langerhans cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988; 137:406-411.
36. Youkeles LH, Grizzanti JN, Liao Z, et al. Decreased tobacco-glycoproteininduced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 1995; 151:145-150.
37. Zeid NA, Muller HK. Tobacco smoke induced lung granulomas and tumors: Association with pulmonary Langerhans cells. Pathology 1995; 27:247-254.
38. Abbott GF, Rosado-de-Christenson ML, Franks TJ, et al. Pulmonary Langerhans cell histiocytosis. Radiographics 2004; 24:821-841.
39. Kambouchner M, Basset F, Marchal J, et al. Three-dimensional characterisation of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 2002; 166:1483-1490.
40. Lacronique J, Roth C, Battesti J-P, et al. Chest radiological features of pulmonary histiocytosis X: A report based on 50 adult cases. Thorax 1982; 37:104-109.
41. Leatherwood DL, Heitkamp DE, Emerson RE. Pulmonary Langerhans cell histiocytosis. Radiographics 2007; 27:265-268.
42. Pomeranz SJ, Proto AV. Histiocytosis X: unusual-confusing features of eosinophilic granuloma. Chest 1986; 89:88-92.
43. ODonnell AE, Tsou E, Awh C, et al. Endobronchial eosinophilic granuloma: A rare cause of total lung atelectasis. Am Rev Respir Dis 1987; 136:1478-1480.
44. Fichtenbaum CJ, Kleinman GM, Haddad RG. Eosinophilic granuloma of the lung presenting as a solitary pulmonary nodule. Thorax 1990; 45:905-906.
45. Von Essen S, West W, Sitorius M, Rennard SI. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990; 98:765-767.
46. Mogulkoc N, Veral A, Bishop PW, et al. Pulmonary Langerhans cell histiocytosis: radiologic resolution following smoking cessation. Chest 1999; 115:1452-1455.
47. Tazi A, Montcelly L, Bergeron A, et al. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 1998; 157:2007-2010.
48. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161:216-223.
49. Moore ADA, Godwin JD, Müller NL, et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989; 172:249-254.
50. Pai U, Tomashefski JF. Occult pulmonary eosinophilic granuloma: An incidental finding in the lungs of cigarette smokers. Am J Clin Pathol 2002; 99:335A; Abstract.
51. Brauner MW, Grenier P, Mouelhi MM, et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989; 172:255-258.
52. Brauner MW, Grenier P, Tijani K, et al. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 1997; 204:497-502.
53. Soler P, Bergeron A, Kambouchner M, et al. Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 2000; 162:264-270.
54. Rappaport DC, Weisbrod GL, Herman SJ, Chamberlain DW. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases. AJR Am J Roentqenol 1989; 152:961-964.
55. Sherrier RH, Chiles C, Roggli V. Pulmonary lymphangioleiomyomatosis: CT findings. AJR Am J Roentqenol 1989; 153:937-940.
56. Aberle DR, Hansell DM, Brown K, Tashkin DP. Lymphangiomyomatosis: CT, chest radiographic, and functional correlations. Radiology 1990; 176:381-387.
57. Austin JHM, Müller NL, Friedman PJ, et al. Glossary of terms for computed tomography of the lungs: recommendations of the nomenclature committee of the Fleischner society. Radiology 1996; 200:327-331.
58. Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965; 39:369-404.
59. Fromm GB, Dunn LJ, Harris JO. Desquamative interstitial pneumonitis: characterization of free intraalveolar cells. Chest 1980; 77:552-554.
60. Travis WD, King TE Jr, and the Multidisciplinary Core Panel. American Thoracic Society/European Respiratory Society international multidiscplinary consensus classification of idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165:277-304.
61. Patchevsky AS, Israel HL, Hoch WS, Gordon G. Desquamative interstitial pneumonia: relationship to interstitial fibrosis. Thorax 1973; 28:680-693.
62. Carrington CB, Gaensler EA, Coutu RE, et al. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298:801-809.
63. Akira M, Yamamoto S, Hara H, et al. Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997; 52:333-337.
64. Feigen DS, Friedman PJ. Chest radiography in desquamative interstitial pneumonitis: A review of 37 patients. AJR Am J Roentgenol 1980; 134: 91-99.
65. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-Associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989; 64:1373-1380.
66. Fraig M, Shreesha U, Savici D, Katzenstein AL. Respiratory bronchiolitis: A clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002; 26:647-653.
67. Herbert A, Sterling G, Abraham J, Corrin B. Desquamative interstitial pneumonia in an aluminium welder. Hum 1982; 13:694-699.
68. Abraham JL, Hertzberg MA. Inorganic particulates associated with desquamative interstitial pneumonia. Chest 1981; 80 (Suppl 1):67-70.
69. Hamadeh MA, Atkinson J, Smith LJ. Sulfasalazine-induced pulmonary disease. Chest 1992; 101:1033-1037.
70. Craig PJ, Wells AU, Doffman S, et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45:275-282.
71. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291: 755-758.
72. Cosio MG, Hale KA, Niewoehner DE. Morphologic and morphometric effects of prolonged cigarette smoking on the small airways. Am Rev Respir Dis 1980; 122:265-271.
73. Myers JL, Veal CF, Shin MS, Katzenstein AA. Respiratory bronchiolitis causing interstitial lung disease: A clinicopathologic study of six cases. Am Rev Respir Dis 1987; 135:880-884.
74. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidiscplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188:733-748.
75. Moon J, du Bois RM, Colby TV, et al. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999; 54:1009-1014.
76. Carilli AD, Kotzen LM, Fischer MJ. The chest roentgenogram in smoking females. Am Rev Respir Dis 1973; 107:133-136.
77. Dick JA, Morgan WKC, Muir DFC, et al. The significance of irregular opacities on the chest roentgenogram. Chest 1992; 102:251-260.
78. Gückel C, Hansell DM. Imaging the dirty lung: has high resolution computed tomography cleared the smoke? Clin Radiol 1998; 53:717-722.
79. Heyneman LE, Ward S, Lynch DA, et al. Respiratory bronchiolitis, respiratory bronchiolitis-Associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol 1999; 173:1617-1622.
80. Hartman TE, Primack SL, Swensen SJ, et al. Desquamative interstitial pneumonia: Thin-section CT findings in 22 patients. Radiology 1993; 187:787-790.
81. Vedal S, Welsh EV, Miller RR, Müller NL. Desquamative interstitial pneumonia: computed tomographic findings before and after treatment with corticosteroids. Chest 1988; 93:215-217.
82. Lynch DA, Travis WD, Müller NL, et al. Idiopathic interstitial pneumonias: CT features. Radiology 2005; 236:10-21.
83. Johkoh T, Müller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211:555-560.
84. Hartman TE, Primack SL, Kang E-Y, et al. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia: Assessment with serial CT. Chest 1996; 110:378-382.
85. Holt RM, Schmidt RA, Godwin JD, Raghu G. High resolution CT in respiratory bronchiolitis-Associated interstitial lung disease. J Comput Assist Tomogr 1993; 17:46-50.
86. Park JS, Brown KK, Tuder RM, et al. Respiratory bronchiolitis-Associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 2002; 26:13-20.
87. Remy-Jardin M, Remy J, Boulenguez C, et al. Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests. Radiology 1993; 186:107-115.
88. Colby TV, Swensen SJ. Anatomic distribution and histopathologic patterns in diffuse lung disease: correlation withHRCT. J Thorac Imaging 1996; 11:1-26.
89. Collins J, Stern EJ. Ground-glass opacity at CT: The ABCs. AJR Am J Roentgenol 1997; 169:355-367.
90. Silver SF, Müller NL, Miller RR, Lefcoe MS. Hypersensitivity pneumonitis: evaluation with CT. Radiology 1989; 173:441-445.
91. Hansell DM, Moskovic E. High-resolution computed tomography in extrinsic allergic alveolitis. Clin Radiol 1991; 43:8-12.
92. Remy-Jardin M, Remy J, Wallaert B, Müller NL. Subacute and chronic bird breeder hypersensitivity pneumonitis: sequential evaluation with CT and correlation with lung function tests and bronchoalveolar lavage. Radiology 1993; 189:111-118.
93. Fraser RS, Müller NL, Colman N, ParéPD. Inhalation of organic dust. In: Fraser RS, Müller NL, Colman N, ParéPD, editors. Diagnosis of diseases of the chest, 4th ed Philadelphia: WB Saunders; 1999. pp. 2361-2385.
94. Auerbach O, Stout AP, Hammond EC, Garfinkel L. Smoking habits and age in relation to pulmonary changes. N Engl J Med 1963; 269:1045-1054.
95. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149:450-454.
96. Churg A, Müller NL, Wright JL. Respiratory bronchiolitis/interstitial lung disease: fibrosis, pulmonary function, and evolving concepts. Arch Pathol Lab Med 2010; 134:27-32.
97. Galvin JR, Franks TJ. Smoking-related lung disease. J Thorac Imaging 2009; 24:274-284.
98. Kawabata Y, Hoshi E, Murai K, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: A semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707-714.
99. Auerbach O, Garfinkel L, Hammond EC. Relation of smoking and age to findings in lung parenchyma: A microscopic study. Chest 2014; 65: 29-35.
100. Washko GR, Hunninghake GW, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364:897-906.
101. Johnston IDA, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997; 52:38-44.
102. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35:171-180.
103. Doherty MJ, Pearson MG, OGrady EA, et al. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997; 52:998-1002.
104. Watadani T, Sakai F, Johkoh T, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 2014; 266:936-944.
105. Marten K, Milne D, Antoniou KM, et al. Nonspecific interstitial pneumonia in cigarette smokers: A CT study. Eur Radiol 2009; 19:1679-1685.